Yang et al. explained a graphene oxide/ssDNA-based biosensor integrated with dual antibody-modified PLLA NPs to amplify electrochemical signals for the effective and rapid electrochemical capture of PSA in serum samples from prostate cancer patients. The gene discussed is KLK3; the disease is prostate carcinoma.